Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Bluebird bio Inc

Bluebird bio Inc

BLUE · NASDAQ
BLUE · NASDAQ

Next Earnings: 07 May 2025

4.08
USD-0.10-2.39%

Latest News

    SeekingAlpha

    bluebird bio confirms Ayrmid has not delivered binding offer, shares dive 9%

      SeekingAlpha

      Key deals this week: xAI acquires X; bluebird bio, Nvidia, Dollar Tree and more

        SeekingAlpha

        bluebird bio sees higher offer for company from Ayrmid Pharma

          SeekingAlpha

          bluebird bio stock slides for second day on buyout news

            CNBC

            Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker - CNBC

              SeekingAlpha

              bluebird bio announces take-private deal with Carlyle and SK Capital

              Analysts Recommendations

              Bullish

              Buy

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              4.05USD
              4.16USD

              52 Week Range

              0.29USD
              10.28USD

              Market Cap

              40.73MUSD

              About

              General Information

              Type

              Common Stock

              Exchange

              NASDAQ

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US09609G2093

              CUSIP

              09609G100

              Sector

              Healthcare

              Industry

              Biotechnology

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              -

              PEG Ratio

              0.32

              Book Value

              -3.24

              Dividend Share

              -

              Dividend Yield

              -

              Earnings Share

              -24.84

              Wall Street Target Price

              6.50

              EPS Estimate Current Year

              0.30

              EPS Estimate Next Year

              -11.50

              EPS Estimate Current Quarter

              -6.295

              EPS Estimate Next Quarter

              -3.8967

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              83,807,000

              Gross Profit TTM

              -5,573,000

              EBITDA

              -206,455,008

              Profit Margin

              -287.23%

              Return On Assets TTM

              -31.00%

              Return On Equity TTM

              -295.35%

              Revenue Per Share TTM

              8.65

              Qtly Revenue Growth YOY

              391.70%

              Diluted Eps TTM

              -24.84

              Qtly Earnings Growth YOY

              0.00%

              Valuation

              Trailing PE

              0.00

              Forward PE

              0

              Price Sales TTM

              0.4895

              Price Book MRQ

              0.726

              Enterprise Value Revenue

              4

              Enterprise Value EBITDA

              -1

              Peers analysis

              • UCB SA ADR
                UCBJYUCB SA ADR

                89.11

                4.76%
              • argenx NV ADR
                ARGXargenx NV ADR

                629.51

                1.44%
              • Vertex Pharmaceuticals Inc
                VRTXVertex Pharmaceuticals Inc

                502.90

                1.32%
              • Alnylam Pharmaceuticals Inc
                ALNYAlnylam Pharmaceuticals Inc

                255.35

                0.15%
              • Be
                ONCBeiGene, Ltd.

                249.77

                0.12%
              • argenx SE
                ARGNFargenx SE

                697.42

                0.00%
              • UCB SA
                UCBJFUCB SA

                150.70

                0.00%
              • Regeneron Pharmaceuticals Inc
                REGNRegeneron Pharmaceuticals Inc

                568.90

                -6.79%
              • CSL Ltd
                CSLLYCSL Ltd

                78.51

                -0.81%
              • CSL Limited
                CMXHFCSL Limited

                156.70

                -0.39%
              XM

              Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

              Trade with a Trusted, Award-Winning Broker.

              Trading involves risk. The value of investments may go up or down. Trade responsibly.

              FAQs

              What is Bluebird bio stock price today?

              What is Bluebird bio stock ticker?

              Is BLUE stock price going up?

              What is the analyst recommendation for BLUE?

              What is BLUE market cap?

              Does BLUE release financial reports?

              When is BLUE next earnings date?

              What were BLUE Earnings for the last quarter?

              What was BLUE Revenue for the last quarter?

              What was BLUE Net Income for the last quarter?

              Does BLUE pay dividends?

              How many employees does BLUE have?

              What is BLUE EBITDA?

              How to buy BLUE stocks?

              Should I invest in BLUE stock?